Giant Biogene Holding Co Ltd
Company Profile
Business description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Contact
No. 1855, Shanglin Yuan 7th Road
Chang’an District
Shaanxi Province
Xi’an
CHNSector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2025
Employees
2,162
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
stocks
Undervalued ASX retailer benefiting from rebound in spending
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,910.40 | 19.50 | -0.22% |
| CAC 40 | 8,124.88 | 56.26 | 0.70% |
| DAX 40 | 24,229.91 | 43.42 | 0.18% |
| Dow JONES (US) | 48,416.56 | 41.49 | -0.09% |
| FTSE 100 | 9,751.31 | 102.28 | 1.06% |
| HKSE | 25,349.05 | 279.83 | -1.09% |
| NASDAQ | 23,057.41 | 137.76 | -0.59% |
| Nikkei 225 | 49,515.14 | 652.97 | -1.30% |
| NZX 50 Index | 13,425.81 | 17.67 | 0.13% |
| S&P 500 | 6,816.51 | 10.90 | -0.16% |
| S&P/ASX 200 | 8,628.20 | 19.10 | -0.22% |
| SSE Composite Index | 3,835.71 | 32.21 | -0.83% |